EUVIMEDEUVIMED entdecken
Crossref

Impact of Calcification on the Outcomes of Femoropopliteal Artery Endovascular Treatment Using a Polymer Coated Drug-Eluting Stent

Ryan Gouveia E Melo, Giovanni Torsello, Angeliki Argyriou, Gregory Chlouverakis, Theodosios Bisdas, Efthymios Beropoulis, Nikolaos Tsilimparis, Konstantinos Stavroulakis

CardioVascular and Interventional Radiology · 2024

DOI: 10.1007/s00270-024-03662-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CardioVascular and Interventional Radiology, 2024. Verfasst von Ryan Gouveia E Melo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Surgery Department, Ludwig Maximilian University Hospital, Campus Grosshadern, Marchioninistrasse 15, 81377, Munich, Germany. ryan@campus.ul…. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Popliteal Artery, Femoral Artery, Vascular Calcification. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The aim of this study was to analyze the impact of calcification on the 12 and 24 months outcomes of the Eluvia™ (Boston Scientific®) drug-eluting stent (DES) for femoropopliteal occlusive disease using three different calcium scoring systems. MATERIAL AND METHODS: A single-center, retrospective cohort-study (March-2016 to December-2018) of patients treated with the Eluvia™ DES for femoropopliteal atherosclerosis was performed. Outcomes included primary and secondary patency rates and freedom from target lesion revascularization (FTLR) and were analyzed by comparing the impact of calcium burden according to the following calcium scores: Peripheral Arterial Calcium Scoring System (PACSS) score, number of vessel quadrants affected (0-4) and calcification score per Peripheral Academic Research Consortium (PARC) definitions. RESULTS: In total, 111 Patients were included (mean age: 71.2 ± 7.9; 64% male). Most patients presented with Rutherford class 3 (79.9%), followed by class 5 (12.7%), class 4 (10%) and class 6 (6.4%). The mean lesion length was 197.6 ± 108.5 mm and 74.3% of patients had chronic total occlusions. There were no differences in primary patency between the calcification scores at 12 months (PACSS, LogRank = 0.28; quadrants, LogRank = 0.29; PARC, LogRank = 0.42) and 24 months (PACSS, LogRank = 0.13; quadrants, LogRank = 0.42; PARC, LogRank = 0.13). FTLR was significantly lower at 12 months in patients with calcification affecting 3 or 4 quadrants (LogRank = 0.022) but not at 24 months (LogRank = 0.36). CONCLUSIONS: In this study, the Eluvia™ DES showed promising performance in calcified disease and the analysis according to the quadrant model predicted an increased risk for TLR at 12 months.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Eluting StentsPopliteal ArteryFemoral ArteryVascular CalcificationPeripheral Arterial DiseaseEndovascular ProceduresHumansMaleFemaleAgedRetrospective StudiesTreatment OutcomeVascular PatencyPolymersMiddle AgedAged, 80 and over

Stichwörter der Autor:innen

CalcificationDrug-eluting stentEluvia™ stentEndovascular revascularization

Substanzen

Polymers

Autor:innen und Institutionen

  • Vascular Surgery Department, Ludwig Maximilian University Hospital, Campus Grosshadern, Marchioninistrasse 15, 81377, Munich, Germany. ryan@campus.ul.pt.
  • Department of Vascular Surgery, St. Franziskus-Hospital GmbH, Münster, Germany.
  • Department of Vascular and Endovascular Surgery, Marien Hospital, Herne, Germany.
  • Division of Biostatistics, School of Medicine, University of Heraklion, Heraklion, Greece.
  • Department of Vascular and Endovascular Surgery, Athens Medical Center, Athens, Greece.
  • Vascular Surgery Department, Ludwig Maximilian University Hospital, Campus Grosshadern, Marchioninistrasse 15, 81377, Munich, Germany.

Zitieren

APA

Gouveia E Melo, R., Torsello, G., Argyriou, A., Chlouverakis, G., Bisdas, T., Beropoulis, E., Tsilimparis, N., & Stavroulakis, K. (2024). Impact of Calcification on the Outcomes of Femoropopliteal Artery Endovascular Treatment Using a Polymer Coated Drug-Eluting Stent. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-024-03662-8

Vancouver

Gouveia E Melo R, Torsello G, Argyriou A, Chlouverakis G, Bisdas T, Beropoulis E, et al. Impact of Calcification on the Outcomes of Femoropopliteal Artery Endovascular Treatment Using a Polymer Coated Drug-Eluting Stent. CardioVascular and Interventional Radiology. 2024. doi:10.1007/s00270-024-03662-8

BibTeX
@article{GouveiaEMelo2024,
  author = {Gouveia E Melo, Ryan and Torsello, Giovanni and Argyriou, Angeliki and Chlouverakis, Gregory and Bisdas, Theodosios and Beropoulis, Efthymios and Tsilimparis, Nikolaos and Stavroulakis, Konstantinos},
  title = {Impact of Calcification on the Outcomes of Femoropopliteal Artery Endovascular Treatment Using a Polymer Coated Drug-Eluting Stent},
  journal = {CardioVascular and Interventional Radiology},
  year = {2024},
  doi = {10.1007/s00270-024-03662-8}
}
Kostenlos starten →